Petrol, Diesel Prices Today In India: On Pause For The 19th Straight Day
Fuel rates were unchanged for the 19th straight day on Monday across all metro cities since a hike of 80 paise per litre on April 6 in petrol and diesel prices.
That comes after a 14-times increase of a cumulative Rs 10 per litre increase in the petrol and diesel rate since price revisions restarted on March 22, following steady rates for nearly four months.
Here are the updates on the petrol and diesel price on April 25, 2022:
In Delhi, a litre of petrol is retailed at ₹ 105.41, and diesel costs ₹ 96.67. In Mumbai, petrol is priced at ₹ 120.51 per litre, and diesel costs ₹ 104.77. In Chennai, petrol is sold at ₹ 110.85 a litre, and diesel costs ₹ 100.94. Petrol is sold at ₹ 115.12 in Chennai, and diesel is priced at ₹ 99.83.Â
If the recent trend of rising Indian crude oil basket prices continues, oil retailers will be forced to hike pump prices.
State retailers set fuel prices each day based on the Dynamic Fuel Price Methodology.
The price revisions method, or the dynamic fuel price methodology, considers several factors such as international crude prices, the exchange rate of the rupee against the dollar, actual and expected demand, and the trade flow in global crude markets.
In addition, central tax or excise duty, value-added tax (VAT) - which varies from state to state, and retailer commission is included to derive from the retail price of fuel.
More than 57 per cent of the retail fuel price per litre goes towards taxes, duties, cess and dealer margins. So those costs included determining the final retail price of fuel at petrol pumps.
States decide on the value-added tax (VAT) varies across states, and Mumbai tops the metros' list for the highest fuel prices.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.